Fri, 19th Mar 2021 14:44
HELSINKI, March 19 (Reuters) - Finland has suspended the use
of AstraZeneca COVID-19 vaccine while it investigates
two possible cases of blood clots, the Finnish Institute for
Health and Welfare said on Friday.
The institute said it estimated that the investigation would
take at least one week. It said earlier this week that it had
received any reports of cases of blood clots among people who
had taken the AstraZeneca vaccine in Finland.
(Reporting by Essi Lehto; editing by Niklas Pollard)
(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...
(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.
(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...
(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...
(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...
Astrazeneca (AZN)